Henry Szechtman, PhD - Publications

Affiliations: 
1980- Psychiatry and Behavioural Neurosciences McMaster University, Hamilton, ON, Canada 
Area:
security motivation, obsessive-compulsive disorder (OCD), dopamine
Website:
http://szechtman.com

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Dorfman A, Szechtman H, Eilam D. Social interaction modulates the intensity of compulsive checking in a rat model of obsessive-compulsive disorder (OCD). Behavioural Brain Research. 359: 156-164. PMID 30389609 DOI: 10.1016/J.Bbr.2018.10.038  0.38
2017 Jung TD, Jung PS, Raveendran L, Farbod Y, Dvorkin-Gheva A, Sakic B, Surette MG, Szechtman H. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole. Behavioural Pharmacology. PMID 29194070 DOI: 10.1097/Fbp.0000000000000363  0.437
2016 Szechtman H, Ahmari SE, Beninger RJ, Eilam D, Harvey BH, Edemann-Callesen H, Winter C. Obsessive-compulsive disorder: Insights from animal models. Neuroscience and Biobehavioral Reviews. PMID 27168347 DOI: 10.1016/J.Neubiorev.2016.04.019  0.375
2016 Johnson EF, Szechtman H. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity. Behavioural Pharmacology. PMID 26871406 DOI: 10.1097/Fbp.0000000000000219  0.386
2015 Hinds AL, Woody EZ, Schmidt LA, Van Ameringen M, Szechtman H. In the wake of a possible mistake: Security motivation, checking behavior, and OCD. Journal of Behavior Therapy and Experimental Psychiatry. PMID 25911281 DOI: 10.1016/J.Jbtep.2015.03.016  0.32
2015 Tucci MC, Dvorkin-Gheva A, Johnson E, Wong M, Szechtman H. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Behavioural Brain Research. 279: 211-7. PMID 25449840 DOI: 10.1016/J.Bbr.2014.11.017  0.363
2015 Ballester González J, Dvorkin-Gheva A, Silva C, Foster JA, Szechtman H. Nucleus accumbens core and pathogenesis of compulsive checking. Behavioural Pharmacology. 26: 200-16. PMID 25426580 DOI: 10.1097/Fbp.0000000000000112  0.403
2014 Tucci MC, Dvorkin-Gheva A, Johnson E, Cheon P, Taji L, Agarwal A, Foster J, Szechtman H. Performance of compulsive behavior in rats is not a unitary phenomenon - validation of separate functional components in compulsive checking behavior. The European Journal of Neuroscience. 40: 2971-9. PMID 24935528 DOI: 10.1111/Ejn.12652  0.397
2014 Tucci MC, Dvorkin-Gheva A, Sharma R, Taji L, Cheon P, Peel J, Kirk A, Szechtman H. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Psychopharmacology. 231: 3707-18. PMID 24682503 DOI: 10.1007/S00213-014-3505-6  0.339
2013 Tucci MC, Dvorkin-Gheva A, Graham D, Amodeo S, Cheon P, Kirk A, Peel J, Taji L, Szechtman H. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Psychopharmacology. 227: 277-85. PMID 23354534 DOI: 10.1007/S00213-013-2976-1  0.337
2013 Alkhatib AH, Dvorkin-Gheva A, Szechtman H. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit. Behavioural Pharmacology. 24: 65-73. PMID 23249525 DOI: 10.1097/Fbp.0B013E32835D5B7A  0.461
2012 Bachus SE, Pellis SM, Rowland NE, Stellar JR, Szechtman H. Introduction to Quo Vadis behavioral neuroscience: a Festschrift for Philip Teitelbaum. Behavioural Brain Research. 231: 231-2. PMID 22521409 DOI: 10.1016/J.Bbr.2012.04.008  0.314
2012 Hinds AL, Woody EZ, van Ameringen M, Schmidt LA, Szechtman H. When too much is not enough: Obsessive-compulsive disorder as a pathology of stopping, rather than starting Plos One. 7. PMID 22291994 DOI: 10.1371/Journal.Pone.0030586  0.331
2010 Dvorkin A, Silva C, McMurran T, Bisnaire L, Foster J, Szechtman H. Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex. The European Journal of Neuroscience. 32: 1552-63. PMID 20731708 DOI: 10.1111/J.1460-9568.2010.07398.X  0.403
2010 Hinds AL, Woody EZ, Drandic A, Schmidt LA, Van Ameringen M, Coroneos M, Szechtman H. The psychology of potential threat: Properties of the security motivation system Biological Psychology. 85: 331-337. PMID 20723575 DOI: 10.1016/J.Biopsycho.2010.08.003  0.319
2010 Dvorkin A, Szechtman H, Golani I. Knots: attractive places with high path tortuosity in mouse open field exploration. Plos Computational Biology. 6: e1000638. PMID 20090825 DOI: 10.1371/Journal.Pcbi.1000638  0.334
2008 Beerepoot P, Lam V, Luu A, Tsoi B, Siebert D, Szechtman H. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neuroscience Letters. 446: 101-4. PMID 18824069 DOI: 10.1016/J.Neulet.2008.09.035  0.397
2008 Culver KE, Szechtman H, Levant B. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049. European Journal of Pharmacology. 592: 67-72. PMID 18644362 DOI: 10.1016/J.Ejphar.2008.06.101  0.417
2008 Dvorkin A, Culver KE, Waxman D, Szechtman H, Kolb B. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder. Behavioural Pharmacology. 19: 271-83. PMID 18622174 DOI: 10.1097/Fbp.0B013E3283095223  0.422
2007 Perreault ML, Seeman P, Szechtman H. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Behavioral Neuroscience. 121: 976-91. PMID 17907829 DOI: 10.1037/0735-7044.121.5.976  0.416
2007 Perreault ML, Graham D, Scattolon S, Wang Y, Szechtman H, Foster JA. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology. 194: 485-96. PMID 17619861 DOI: 10.1007/S00213-007-0855-3  0.372
2006 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse (New York, N.Y.). 60: 319-46. PMID 16786561 DOI: 10.1002/Syn.20303  0.374
2006 Dvorkin A, Culver KE, Szechtman H. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments. Psychopharmacology. 186: 534-43. PMID 16758240 DOI: 10.1007/S00213-006-0377-4  0.396
2006 Dvorkin A, Perreault ML, Szechtman H. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder. Behavioural Brain Research. 169: 303-11. PMID 16524632 DOI: 10.1016/J.Bbr.2006.01.024  0.462
2006 Eilam D, Zor R, Szechtman H, Hermesh H. Rituals, stereotypy and compulsive behavior in animals and humans. Neuroscience and Biobehavioral Reviews. 30: 456-71. PMID 16253329 DOI: 10.1016/J.Neubiorev.2005.08.003  0.329
2006 Perreault ML, Graham D, Bisnaire L, Simms J, Hayton S, Szechtman H. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1967-81. PMID 16237381 DOI: 10.1038/Sj.Npp.1300938  0.399
2006 Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behavioural Brain Research. 166: 32-8. PMID 16183144 DOI: 10.1016/J.Bbr.2005.07.030  0.399
2006 Szechtman H, Eilam D. S.15.02 Dopamine model of OCD in rats European Neuropsychopharmacology. 16: S186. DOI: 10.1016/S0924-977X(06)70075-X  0.36
2005 Eilam D, Szechtman H. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals. Cns Spectrums. 10: 191-202. PMID 15744221 DOI: 10.1017/S109285290001004X  0.449
2004 Lomanowska A, Gormley S, Szechtman H. Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 77: 617-22. PMID 15006474 DOI: 10.1016/J.Pbb.2003.12.018  0.721
2004 Culver KE, Szechtman H. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline. Hormones and Behavior. 45: 23-30. PMID 14733888 DOI: 10.1016/J.Yhbeh.2003.07.004  0.456
2003 Gabriele J, Culver K, Sharma S, Zhang B, Szechtman H, Mishra R. Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration. Synapse (New York, N.Y.). 49: 261-9. PMID 12827645 DOI: 10.1002/Syn.10224  0.389
2003 Culver KE, Szechtman H. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors. Psychopharmacology. 167: 211-8. PMID 12652347 DOI: 10.1007/S00213-003-1408-Z  0.387
2002 Culver KE, Rosenfeld JM, Szechtman H. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology. 43: 385-93. PMID 12243768 DOI: 10.1016/S0028-3908(02)00128-4  0.428
2002 Sakic B, Lacosta S, Denburg JA, Szechtman H. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. Journal of Neuroimmunology. 129: 84-96. PMID 12161024 DOI: 10.1016/S0165-5728(02)00171-6  0.427
2002 Szumlinski KK, Szechtman H. D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation. Neuroreport. 13: 563-6. PMID 11973446 DOI: 10.1097/00001756-200204160-00005  0.362
2002 Shaldubina A, Einat H, Szechtman H, Shimon H, Belmaker RH. Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 433-40. PMID 11956963 DOI: 10.1007/S007020200035  0.348
2002 Tizabi Y, Louis VA, Taylor CT, Waxman D, Culver KE, Szechtman H. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder. Biological Psychiatry. 51: 164-71. PMID 11822995 DOI: 10.1016/S0006-3223(01)01207-0  0.421
2001 Ben-Pazi A, Szechtman H, Eilam D. The morphogenesis of motor rituals in rats treated chronically with the dopamine agonist quinpirole. Behavioral Neuroscience. 115: 1301-17. PMID 11770061 DOI: 10.1037//0735-7044.115.6.1301  0.385
2001 Maric D, Millward JM, Ballok DA, Szechtman H, Denburg JA, Barker JL, Sakic B. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Research. 920: 183-93. PMID 11716824 DOI: 10.1016/S0006-8993(01)03060-8  0.31
2001 Szechtman H, Eckert MJ, Tse WS, Boersma JT, Bonura CA, McClelland JZ, Culver KE, Eilam D. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control. Bmc Neuroscience. 2: 4. PMID 11316464 DOI: 10.1186/1471-2202-2-4  0.434
2001 Sakić B, Gauldie J, Denburg JA, Szechtman H. Behavioral effects of infection with IL-6 adenovector. Brain, Behavior, and Immunity. 15: 25-42. PMID 11259078 DOI: 10.1006/Brbi.1999.0576  0.302
2000 Szumlinski KK, Goodwill AM, Szechtman H. Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex. Psychopharmacology. 152: 304-11. PMID 11105941 DOI: 10.1007/S002130000538  0.429
2000 Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? Journal of Neuroimmunology. 111: 93-101. PMID 11063826 DOI: 10.1016/S0165-5728(00)00364-7  0.318
2000 Culver KE, Rosenfeld JM, Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology. 151: 202-10. PMID 10972466 DOI: 10.1007/S002139900346  0.36
1999 Szechtman H, Culver K, Eilam D. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Polish Journal of Pharmacology. 51: 55-61. PMID 10389145  0.318
1999 Sakić B, Laflamme N, Crnic LS, Szechtman H, Denburg JA, Rivest S. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. Journal of Neuroimmunology. 96: 80-91. PMID 10227427 DOI: 10.1016/S0165-5728(99)00021-1  0.335
1998 Szechtman H, Sulis W, Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behavioral Neuroscience. 112: 1475-85. PMID 9926830 DOI: 10.1037/0735-7044.112.6.1475  0.425
1998 Coscina DV, Currie PJ, Szechtman H. Association of altered whole-body metabolism with locomotor sensitization induced by quinpirole. Physiology & Behavior. 63: 755-61. PMID 9617996 DOI: 10.1016/S0031-9384(97)00531-3  0.422
1998 Sullivan RM, Talangbayan H, Einat H, Szechtman H. Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience. 83: 781-9. PMID 9483561 DOI: 10.1016/S0306-4522(97)00412-0  0.387
1997 Culver KE, Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. European Journal of Pharmacology. 339: 109-11. PMID 9473123 DOI: 10.1016/S0014-2999(97)01386-1  0.338
1997 Szumlinski KK, Allan M, Talangbayan H, Tracey A, Szechtman H. Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology. 134: 193-200. PMID 9399384 DOI: 10.1007/S002130050442  0.369
1997 Farrell M, Sakić B, Szechtman H, Denburg JA. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice. Lupus. 6: 268-74. PMID 9104735 DOI: 10.1177/096120339700600310  0.301
1997 MacFarlane JG, List SJ, Moldofsky H, Firnau G, Chen JJ, Szechtman H, Garnett S, Nahmias C. Dopamine D2 receptors quantified in vivo in human narcolepsy. Biological Psychiatry. 41: 305-10. PMID 9024953 DOI: 10.1016/S0006-3223(96)00003-0  0.315
1997 Eilam D, Szechtman H. A plausible rat model of obsessive-compulsive disorder: Compulsive checking behavior is induced in rats chronically injected with quinpirole Neuroscience Letters. 237: S16. DOI: 10.1016/S0304-3940(97)90063-X  0.386
1996 Sakić B, Denburg JA, Denburg SD, Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Research Bulletin. 41: 305-11. PMID 8924042 DOI: 10.1016/S0361-9230(96)00190-6  0.332
1996 Einat H, Einat D, Allan M, Talangbayan H, Tsafnat T, Szechtman H. Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology. 127: 95-101. PMID 8888373 DOI: 10.1007/Bf02805980  0.366
1996 Sakić B, Szechtman H, Stead RH, Denburg JA. Joint pathology and behavioral performance in autoimmune MRL-lpr Mice. Physiology & Behavior. 60: 901-5. PMID 8873267 DOI: 10.1016/0031-9384(96)00065-0  0.321
1995 Sakić B, Szechtman H, Denburg SD, Denburg JA. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiology & Behavior. 58: 797-802. PMID 8559794 DOI: 10.1016/0031-9384(95)00135-6  0.354
1995 Einat H, Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiology & Behavior. 57: 55-9. PMID 7878126 DOI: 10.1016/0031-9384(94)00209-N  0.446
1995 Sullivan RM, Szechtman H. Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology. Neuroscience. 65: 757-66. PMID 7609874 DOI: 10.1016/0306-4522(94)00531-9  0.348
1994 Sullivan RM, Fraser A, Szechtman H. Asymmetrical orientation to edges of an openfield: modulation by striatal dopamine and relationship to motor asymmetries in the rat. Brain Research. 637: 114-8. PMID 8180788 DOI: 10.1016/0006-8993(94)91223-8  0.405
1994 Sullivan RM, Szechtman H. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats. Neuroscience Letters. 170: 83-6. PMID 8041518 DOI: 10.1016/0304-3940(94)90244-5  0.344
1994 Sakić B, Szechtman H, Talangbayan H, Denburg S, Carbotte R, Denburg JA. Behavior and immune status of MRL mice in the postweaning period. Brain, Behavior, and Immunity. 8: 1-13. PMID 8003767 DOI: 10.1006/Brbi.1994.1001  0.35
1994 Sakić B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. Disturbed emotionality in autoimmune MRL-lpr mice. Physiology & Behavior. 56: 609-17. PMID 7972416 DOI: 10.1016/0031-9384(94)90309-3  0.317
1994 Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 48: 921-8. PMID 7972297 DOI: 10.1016/0091-3057(94)90201-1  0.403
1994 Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology. 115: 95-104. PMID 7862919 DOI: 10.1007/Bf02244757  0.434
1993 Szechtman H, Talangbayan H, Eilam D. Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behavioural Pharmacology. 4: 405-410. PMID 11224209 DOI: 10.1097/00008877-199308000-00014  0.391
1993 Einat H, Szechtman H. Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole. Behavioural Pharmacology. 4: 399-403. PMID 11224208 DOI: 10.1097/00008877-199308000-00013  0.414
1993 Sullivan RM, Parker BA, Szechtman H. Role of the corpus callosum in expression of behavioral asymmetries induced by a unilateral dopamine lesion of the substantia nigra in the rat. Brain Research. 609: 347-50. PMID 8508317 DOI: 10.1016/0006-8993(93)90895-T  0.39
1993 Sakić B, Szechtman H, Denburg S, Carbotte R, Denburg JA. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiology & Behavior. 54: 1025-9. PMID 8248368 DOI: 10.1016/0031-9384(93)90319-B  0.344
1993 Eilam D, Szechtman H, Faigon M, Dubovik V, Feldon J, Michaelson DM. Disintegration of the spatial organization of behavior in experimental autoimmune dementia. Neuroscience. 56: 83-91. PMID 8232920 DOI: 10.1016/0306-4522(93)90564-V  0.328
1993 Einat H, Szechtman H. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behavioural Brain Research. 54: 35-41. PMID 8099289 DOI: 10.1016/0166-4328(93)90046-S  0.439
1992 Eilam D, Talangbayan H, Canaran G, Szechtman H. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors Psychopharmacology. 106: 447-454. PMID 1533720 DOI: 10.1007/Bf02244813  0.364
1992 Sakić B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. A behavioral profile of autoimmune lupus-prone MRL mice. Brain, Behavior, and Immunity. 6: 265-85. PMID 1392101 DOI: 10.1016/0889-1591(92)90048-S  0.307
1992 Sullivan R, Dogaru C, Szechtman H. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 43: 1217-9. PMID 1361993 DOI: 10.1016/0091-3057(92)90505-A  0.42
1992 Eilam D, Szechtman H, Spear LP. Quinpirole alters quadruped activity in rats from the second postnatal week. Developmental Psychobiology. 25: 275-89. PMID 1352505 DOI: 10.1002/Dev.420250405  0.376
1991 Cleghorn JM, Szechtman H, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman B, Franco S. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients Psychiatry Research. 40: 135-153. PMID 1763143 DOI: 10.1016/0925-4927(91)90005-B  0.301
1991 Eilam D, Clements KVA, Szechtman H. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats Behavioural Brain Research. 45: 117-124. PMID 1686397 DOI: 10.1016/S0166-4328(05)80077-4  0.366
1991 Cleghorn J, Szechtman H, Garnett E, Nahmias C, Kaplan R, Brown G, Franco S. Regional brain glucose metabolism in neuroleptic naive first episode and chronic schizophrenic patients and normal controls at rest and after dopamine agonist and antagonist drugs Schizophrenia Research. 4: 401-402. DOI: 10.1016/0920-9964(91)90349-V  0.328
1990 Ziegler MG, Szechtman H. Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system. Behavioural Brain Research. 39: 123-33. PMID 2390196 DOI: 10.1016/0166-4328(90)90099-Z  0.377
1990 Eilam D, Szechtman H. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole Pharmacology, Biochemistry and Behavior. 36: 989-991. PMID 1977180 DOI: 10.1016/0091-3057(90)90111-T  0.354
1989 Eilam D, Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements European Journal of Pharmacology. 161: 151-157. PMID 2566488 DOI: 10.1016/0014-2999(89)90837-6  0.366
1989 Eilam D, Golani I, Szechtman H. D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Research. 490: 255-67. PMID 2527582 DOI: 10.1016/0006-8993(89)90243-6  0.394
1988 Szechtman H, Cleghorn JM, Brown GM, Kaplan RD, Franco S, Rosenthal K. Sensitization and tolerance to apomorphine in men: Yawning, growth hormone, nausea, and hyperthermia Psychiatry Research. 23: 245-255. PMID 3387500 DOI: 10.1016/0165-1781(88)90015-7  0.339
1988 Szechtman H. Effect of the dopamine receptor agonist apomorphine on sensory input Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 489-496. PMID 3244390 DOI: 10.1007/Bf00179319  0.363
1988 Ziegler M, Szechtman H. Differences in the Behavioral Profile of Circling Under Amphetamine and Apomorphine in Rats With Unilateral Lesions of the Substantia Nigra Behavioral Neuroscience. 102: 276-288. PMID 3130074 DOI: 10.1037//0735-7044.102.2.276  0.416
1988 Szechtman H, Eilam D, Teitelbaum P, Golani I. A different look at measurement and interpretation of drug-induced stereotyped behavior Psychobiology. 16: 164-173. DOI: 10.3758/Bf03333121  0.338
1987 Vanderwolf CH, Szechtman H. Electrophysiological correlates of stereotyped sniffing in rats injected with apomorphine. Pharmacology, Biochemistry, and Behavior. 26: 299-304. PMID 3575354 DOI: 10.1016/0091-3057(87)90122-5  0.358
1986 Pisa M, Szechtman H. Lateralized and compulsive exteroceptive orientation in rats treated with apomorphine Neuroscience Letters. 64: 41-46. PMID 3960386 DOI: 10.1016/0304-3940(86)90660-9  0.428
1986 Szechtman H. Behavior performed at onset of drug action and apomorphine stereotypy European Journal of Pharmacology. 121: 49-56. PMID 3956573 DOI: 10.1016/0014-2999(86)90391-2  0.402
1986 Szechtman H, Pisa M. Postural asymmetry and lateralized rotation in normal rats administered apomorphine Pharmacology, Biochemistry and Behavior. 25: 689-691. PMID 3774835 DOI: 10.1016/0091-3057(86)90160-7  0.402
1986 Szechtman H. Effects of pretreatment with naloxone on behaviours induced by a small dose of apomorphine Pharmacology, Biochemistry and Behavior. 24: 1779-1783. PMID 3737643 DOI: 10.1016/0091-3057(86)90520-4  0.357
1985 Pisa M, Szechtman H. Lateralizing effects of apomorphine on taxis, postural support and rotation in rats Progress in Neuropsychopharmacology and Biological Psychiatry. 9: 525-531. PMID 4089183 DOI: 10.1016/0278-5846(85)90012-0  0.402
1985 Szechtman H, Adler NT, Komisaruk BR. Mating induces pupillary dilatation in female rats: role of pelvic nerve. Physiology & Behavior. 35: 295-301. PMID 4070399 DOI: 10.1016/0031-9384(85)90352-X  0.305
1985 Szechtman H, Ornstein K, Teitelbaum P, Golani I. The morphogenesis of stereotyped behavior induced by the dopamine receptor agonist apomorphine in the laboratory rat. Neuroscience. 14: 783-98. PMID 2986045 DOI: 10.1016/0306-4522(85)90143-5  0.403
1984 Szechtman H. Timing of yawns induced by a small dose of apomorphine and its alteration by naloxone Progress in Neuropsychopharmacology and Biological Psychiatry. 8: 743-746. PMID 6531446 DOI: 10.1016/0278-5846(84)90050-2  0.367
1983 Szechtman H. Peripheral sensory input directs apomorphine-induced circling in rats Brain Research. 264: 332-335. PMID 6850305 DOI: 10.1016/0006-8993(83)90836-3  0.36
1982 Szechtman H, Ornstein K, Teitelbaum P, Golani I. Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains. European Journal of Pharmacology. 80: 385-92. PMID 7201932 DOI: 10.1016/0014-2999(82)90084-X  0.369
1982 Burns TG, Szechtman H, Brown GM, Snieckus V. Behavioral effects of 5-hydroxy-N-acetyltryptophan, a putative synthetic precursor of N-acetylserotonin Progress in Neuropsychopharmacology and Biological Psychiatry. 6: 359-363. PMID 6984517 DOI: 10.1016/S0278-5846(82)80107-3  0.33
1981 Kalcheim C, Szechtman H, Koch Y. Bisexual behavior in male rats treated neonatally with antibodies to luteinizing hormone-releasing hormone. Journal of Comparative and Physiological Psychology. 95: 36-44. PMID 7012206 DOI: 10.1037/H0077762  0.33
1981 Szechtman H, Hershkowitz M, Simantov R. Sexual behavior decreases pain sensitivity and stimulates endogenous opioids in male rats European Journal of Pharmacology. 70: 279-285. PMID 6262094 DOI: 10.1016/0014-2999(81)90161-8  0.362
1980 Szechtman H, Hall WG. Ontogeny of oral behavior induced by tail pinch and electrical stimulation of the tail in rats. Journal of Comparative and Physiological Psychology. 94: 436-45. PMID 7391280 DOI: 10.1037/H0077683  0.345
1980 Szechtman H. Redirected oral behavior in rats induced by tail-pinch and electrical stimulation of the tail Physiology and Behavior. 24: 57-64. PMID 7384251 DOI: 10.1016/0031-9384(80)90014-1  0.326
1979 Szechtman H, Levy I. An automatic device for delivering "tail-pinch" stimulation to freely moving rats Physiology and Behavior. 23: 197-199. PMID 515211 DOI: 10.1016/0031-9384(79)90144-6  0.305
1979 Hershkowitz M, Szechtman H. Pretreatment with δ1-tetrahydrocannabinol and psychoactive drugs: Effects on uptake of biogenic amines and on behavior European Journal of Pharmacology. 59: 267-276. PMID 230975 DOI: 10.1016/0014-2999(79)90290-5  0.349
1978 Szechtman H, Caggiula AR, Wulkan D. Preoptic knife cuts and sexual behavior in male rats. Brain Research. 150: 569-95. PMID 307976 DOI: 10.1016/0006-8993(78)90821-1  0.609
1977 Szechtman H, Siegel HI, Rosemblatt JS, Komisaruk BR. Tail-pinch facilitates onset of maternal behavior in rats. Physiology & Behavior. 19: 807-9. PMID 609620 DOI: 10.1016/0031-9384(77)90319-5  0.379
1976 Antelman SM, Szechtman H, Chin P, Fisher AE. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics. The Journal of Pharmacy and Pharmacology. 28: 66-8. PMID 6656 DOI: 10.1111/J.2042-7158.1976.Tb04028.X  0.304
1975 Antelman SM, Szechtman H, Chin P, Fisher AE. Tail pinch-induced eating, gnawing and licking behavior in rats: dependence on the nigrostriatal dopamine system. Brain Research. 99: 319-37. PMID 1182545 DOI: 10.1016/0006-8993(75)90032-3  0.432
1975 Antelman SM, Szechtman H. Tail pinch induces eating in sated rats which appears to depend on nigrostriatal dopamine Science. 189: 731-733. PMID 1154024 DOI: 10.1126/Science.1154024  0.444
1974 Szechtman H, Lambrou PJ, Caggiula AR, Redgate ES. Plasma corticosterone levels during sexual behavior in male rats. Hormones and Behavior. 5: 191-200. PMID 4847187 DOI: 10.1016/0018-506X(74)90043-9  0.573
1972 Caggiula AR, Szechtman H. Hypothalamic stimulation: a biphasic influence on copulation of the male rat. Behavioral Biology. 7: 591-8. PMID 5050144 DOI: 10.1016/S0091-6773(72)80221-9  0.602
Show low-probability matches.